Brio Pharma Technologies Private Limited

Brio Pharma Technologies Private Limited - machinery and equipment in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U51496MH2005PTC157234 Incorporated 10 November 2005 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company machinery and equipment MSME · Micro
Data last updated
Revenue · FY 2025
₹9.96 Cr
▼ 13% YoY
Net loss · FY 2025
₹12.55 Lakh
Net margin -1.3%
EBITDA · FY 2025
₹40.62 Lakh
EBITDA margin 4.1%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Company age
21 yrs
Est. 2005
Employees · EPFO
9
Provident fund records
Directors on board
4
As per MCA filings

About Brio Pharma Technologies Private Limited

Data last updated:

Brio Pharma Technologies Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial products retail and distribution segment of the machinery and industrial equipment sector. It was incorporated on 10 November 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51496MH2005PTC157234. Its GSTIN is 27AACCB7462L2ZB (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Deelish Narayanan Kapadan and Deepak Virbhadra Kabbur.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.96 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹12.55 Lakh (net margin -1.3%) and EBITDA of ₹40.62 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 119% over three years and 38% over five years.

The company has about 9 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Brio Pharma Technologies.

Brio Pharma Technologies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0119852). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website briopharmatech.com.

Company details

CIN U51496MH2005PTC157234
Registration Number 157234
Incorporation Date 10 November 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0119852

Recognitions & Rankings of Brio Pharma Technologies

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-33-0119852

Contact details

Brio Pharma Technologies Private Limited's registered office is in Thane, Maharashtra. Its website is briopharmatech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Office No. A – 705 & 706 Arihant Aura, Plot No.13/1 Ttc Industrial Area Turbhe MIDC, Thane, Maharashtra, India – 400703
  • Industry
    Machinery and Equipment, Industrial Products Retail & Distribution

To see the full contact details of Brio Pharma Technologies Private Limited, buy the company report.

Comprehensive company report
Brio Pharma Technologies Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Brio Pharma Technologies operates one associated brand: Brio Pharma Technologies. Each brand links to its own profile.

BrandDescriptionWebsite
Provision of technology solutions for pharmaceutical processing and packaging.briopharmatech.com

Business activity

The main business activity of Brio Pharma Technologies is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Brio Pharma Technologies Private Limited, buy the company report.

Financials of Brio Pharma Technologies Private Limited

FY 2024 filings available

Brio Pharma Technologies Private Limited reported revenue of ₹9.96 Cr (down 13% YoY) for FY 2025.

Revenue · FY 2025
₹9.96 Cr ▼ 13%
Net loss · FY 2025
₹12.55 Lakh margin -1.3%
EBITDA · FY 2025
₹40.62 Lakh margin 4.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▲ 119%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▼ 83%
3 years · compounded
▲ 43%
5 years · compounded
▲ 19%

Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹40.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹12.55 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.1%
Net Profit Margin-1.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Brio Pharma Technologies Private Limited, buy the company report.

Board of directors of Brio Pharma Technologies Private Limited

Brio Pharma Technologies has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Deelish Narayanan KapadanDirector31 Jan 20188 Years 8 MonthsCurrent
Deepak Virbhadra KabburDirector11 Aug 20215 Years 2 MonthsCurrent
Mithila Shubham MishraDirector11 Aug 20215 Years 2 MonthsCurrent
Shubham Suresh MishraDirector10 Nov 200520 Years 11 MonthsCurrent

Auditor

Brio Pharma Technologies Private Limited is audited by MEHUL GOSAR & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MEHUL GOSAR & ASSOCIATESFY 2023156433W

Shareholding

The shareholding of Brio Pharma Technologies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Brio Pharma Technologies Private Limited, buy the company report.

MSME payment delays

Brio Pharma Technologies Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
an individual supplier

To see the full MSME payment records of Brio Pharma Technologies Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Brio Pharma Technologies Private Limited has a workforce of 9 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.

Employee count
9
Active EPFO establishments
1
Employee growth
-25%

GST

Brio Pharma Technologies has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AACCB7462L2ZBMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Brio Pharma Technologies Private Limited, buy the company report.

Recent activity

Brio Pharma Technologies Private Limited has 10 board changes on record since 2005: 4 appointments and 6 cessations. The latest: Deepak Virbhadra Kabbur ceased to be Additional Director on 30 Nov 2021.

AGM
Brio Pharma Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Brio Pharma Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Deepak Virbhadra Kabbur ceased to be Additional Director.
Ceased
Mithila Shubham Mishra ceased to be Additional Director.
Appointed
Deepak Virbhadra Kabbur was appointed as Director.
Appointed
Mithila Shubham Mishra was appointed as Director.
Ceased
Vijayalakshmi Mishra ceased to be Director.
Appointed
Deelish Narayanan Kapadan was appointed as Director.
Ceased
Giovanni Peccholi ceased to be Director.
Ceased
Gaetano Castiglione ceased to be Director.
Ceased
Jayaraman Krishnan Chittur ceased to be Director.
Appointed
Shubham Suresh Mishra was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Brio Pharma Technologies is an active private limited company based in Thane, Maharashtra, India. The company works in industrial products retail and distribution, within the machinery and equipment industry. It was incorporated on 10 November 2005 (21+ years old) and is registered under CIN U51496MH2005PTC157234.

Brio Pharma Technologies has 4 current directors:

The latest financial statements of Brio Pharma Technologies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Brio Pharma Technologies is 27AACCB7462L2ZB, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Brio Pharma Technologies is U51496MH2005PTC157234. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Brio Pharma Technologies was incorporated on 10 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Deepak Virbhadra Kabbur ceased to be Additional Director on 30 Nov 2021. Mithila Shubham Mishra ceased to be Additional Director on 30 Nov 2021. Deepak Virbhadra Kabbur was appointed as Director on 11 Aug 2021. Brio Pharma Technologies has 10 board changes on record in total.

Yes, Brio Pharma Technologies is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0119852).

Brio Pharma Technologies has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 09 Jun 2019.

Brio Pharma Technologies can be reached through the website briopharmatech.com. Its registered office is in Thane, Maharashtra, India.

The registered office of Brio Pharma Technologies is at Office No. A – 705 & 706 Arihant Aura, Plot No.131 Ttc Industrial Area Turbhe MIDC, Thane, Maharashtra, India – 400703.